Menendez, Collins Introduce Bipartisan Bill To Ensure Diversity In NIH Clinical Trials
December 16, 2022
December 16, 2022
WASHINGTON, Dec. 16 -- Sen. Robert Menendez, D-New Jersey, issued the following news release on Dec. 15, 2022:
U.S. Senators Bob Menendez (D-N.J.) and Susan Collins (R-Maine) today introduced bipartisan legislation to increase the diversity of participants in all National Institutes of Health (NIH)-funded trials. The NIH Clinical Trial Diversity Act builds upon the NIH's current policies to enhance the inclusion of women, racially and ethnically diverse individuals and people a . . .
U.S. Senators Bob Menendez (D-N.J.) and Susan Collins (R-Maine) today introduced bipartisan legislation to increase the diversity of participants in all National Institutes of Health (NIH)-funded trials. The NIH Clinical Trial Diversity Act builds upon the NIH's current policies to enhance the inclusion of women, racially and ethnically diverse individuals and people a . . .